Virtu Financial’s MIRA Pharmaceuticals MIRA Stock Holding History

Virtu Financial’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,196	Closed	-$17K	–	2008
2025 Q3	$17K	Buy	+12,196	New	+$17.7K	﹤0.01%	1296
2025 Q1	–	Sell	-63,410	Closed	-$72K	–	1769
2024 Q4	$72K	Buy	+63,410	New	+$82.8K	﹤0.01%	1094
2024 Q2	–	Sell	-63,055	Closed	-$69K	–	1661
2024 Q1	$69K	Buy	63,055 +48,397	+330%	+$52.5K	0.01%	976
2023 Q4	$15K	Buy	+14,658	New	+$37.2K	﹤0.01%	1364

Other funds holding MIRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Virtu Financial's MIRA Position: Q4 2025 in Review

Virtu Financial sold out of MIRA Pharmaceuticals (MIRA) in Q4 2025, closing a stake of 12,196 shares — an estimated $17K sold.

Virtu Financial first reported a position in MIRA in Q4 2023 and held it in 4 quarters. The position peaked at $72K in Q4 2024. 25 funds tracked by Wall St. Rank hold MIRA as of Q4 2025.

Virtu Financial reported no remaining MIRA Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 12,196 MIRA Pharmaceuticals shares in Q4 2025, an estimated $17K.
Virtu Financial first reported a position in MIRA Pharmaceuticals in Q4 2023 and held it in 4 quarters.
Virtu Financial's MIRA Pharmaceuticals position peaked at $72K in Q4 2024.
25 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.